 19. Concomitant use of drugs that are metabolized through cytochrome P450, family 2, subfamily C, polypeptide 19 CYP2C19 omeprazole and esomeprazole, fluvoxamine, fluoxetine, moclobemide, voriconazole, fluconazole, ticlopidine, ciprofloxacin, cimetidine, carbamazepine, oxcarbazepine and chloramphenicol. 